DK0894136T3 - Fremgangsmåde til behandling af muskulære lidelser - Google Patents

Fremgangsmåde til behandling af muskulære lidelser

Info

Publication number
DK0894136T3
DK0894136T3 DK97906296T DK97906296T DK0894136T3 DK 0894136 T3 DK0894136 T3 DK 0894136T3 DK 97906296 T DK97906296 T DK 97906296T DK 97906296 T DK97906296 T DK 97906296T DK 0894136 T3 DK0894136 T3 DK 0894136T3
Authority
DK
Denmark
Prior art keywords
muscular disorders
treating muscular
treating
disorders
igf
Prior art date
Application number
DK97906296T
Other languages
English (en)
Inventor
Shi Yu Yang
Geoffrey Royal Free Goldspink
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of DK0894136T3 publication Critical patent/DK0894136T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97906296T 1996-03-11 1997-03-11 Fremgangsmåde til behandling af muskulære lidelser DK0894136T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605124.8A GB9605124D0 (en) 1996-03-11 1996-03-11 Method of treating muscular disorders

Publications (1)

Publication Number Publication Date
DK0894136T3 true DK0894136T3 (da) 2006-09-18

Family

ID=10790201

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06003275.2T DK1726651T3 (da) 1996-03-11 1997-03-11 Fremgangsmåde til behandling af muskulære lidelser
DK97906296T DK0894136T3 (da) 1996-03-11 1997-03-11 Fremgangsmåde til behandling af muskulære lidelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06003275.2T DK1726651T3 (da) 1996-03-11 1997-03-11 Fremgangsmåde til behandling af muskulære lidelser

Country Status (10)

Country Link
US (1) US6221842B1 (da)
EP (2) EP1726651B1 (da)
JP (1) JP2000506729A (da)
AT (2) ATE326534T1 (da)
DE (2) DE69735883T2 (da)
DK (2) DK1726651T3 (da)
ES (2) ES2265649T3 (da)
GB (1) GB9605124D0 (da)
PT (2) PT894136E (da)
WO (1) WO1997033997A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031517A1 (en) * 1994-05-16 1995-11-23 Shell Internationale Research Maatschappij B.V. Process for upgrading residual hydrocarbon oils
US7700353B2 (en) * 1998-07-22 2010-04-20 E-P Therapeutics, Inc. Compositions and methods for inducing apoptosis in tumor cells
US7118752B2 (en) * 1998-07-22 2006-10-10 University Of Connecticut Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I
GB9926968D0 (en) * 1999-11-15 2000-01-12 Univ London Treatment of neurological disorders
GB0011278D0 (en) 2000-05-10 2000-06-28 Univ London Repair of nerve damage
FR2829498B1 (fr) * 2001-09-11 2003-11-28 Merial Sas Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
US7326417B2 (en) 2001-09-11 2008-02-05 Merial Ltd. IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
GB0202906D0 (en) * 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
US20050125914A1 (en) * 2003-11-18 2005-06-16 Gerard Malle Hair shaping composition comprising at least one- non-hydroxide base
WO2006097682A1 (en) * 2005-03-18 2006-09-21 Ucl Business Plc Mechano growth factor peptides and their use
US20090221072A1 (en) * 2006-02-15 2009-09-03 Chen Thomas T Compositions and methods for modulating cell differentiation
WO2007146689A2 (en) 2006-06-09 2007-12-21 Novartis Ag Stabilized insulin-like growth factor polypeptides
CN101466399B (zh) * 2006-06-09 2015-05-13 诺华股份有限公司 稳定的胰岛素样生长因子多肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
SE9100099D0 (sv) 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
AU1178395A (en) * 1993-11-12 1995-05-29 North Shore University Hospital Research Corporation Method of treating muscular dystrophy

Also Published As

Publication number Publication date
EP1726651A1 (en) 2006-11-29
ES2265649T3 (es) 2007-02-16
DK1726651T3 (da) 2010-04-12
EP0894136A1 (en) 1999-02-03
DE69735883D1 (de) 2006-06-22
PT1726651E (pt) 2010-04-08
JP2000506729A (ja) 2000-06-06
WO1997033997A1 (en) 1997-09-18
DE69735883T2 (de) 2007-04-19
US6221842B1 (en) 2001-04-24
ATE326534T1 (de) 2006-06-15
ES2337917T3 (es) 2010-04-30
GB9605124D0 (en) 1996-05-08
EP0894136B1 (en) 2006-05-17
ATE454451T1 (de) 2010-01-15
EP1726651B1 (en) 2010-01-06
DE69739737D1 (de) 2010-02-25
PT894136E (pt) 2006-10-31

Similar Documents

Publication Publication Date Title
DK0927024T3 (da) Indretning og fremgangsmåde til behandling af öjensygdomme
NO990851D0 (no) Forbedret apparat for ultralyd-terapeutisk behandling
DE69722426D1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
DK1726651T3 (da) Fremgangsmåde til behandling af muskulære lidelser
ES2063912T3 (es) Composiciones inmunogenicas frente a peptidos de gastrina.
DE68929475D1 (de) Wässrige Copolymer-Dispersion zur Lederbehandlung
NO985066D0 (no) Terapeutisk behandling for VEGF-relaterte sykdommer
ATE247504T1 (de) Vorrichtung zur behandlung des menschlichen körpers durch endermatische elektrotherapie
AU8091787A (en) The use of paroxetine to treat pain
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
EP0515434A4 (en) Method for treating intestinal diseases
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
EP0967276A3 (en) Anti-tumor agent comprising salmosin
IT240104Y1 (it) Dispositivo per il trattamento del corpo umano.
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
DK664188D0 (da) Butylhydroxyanisoler til behandling af retrovirale sygdomme
PT1304107E (pt) Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
IT1285552B1 (it) Dispositivo e metodo per il trattamento di parti del corpo umano
RU97121459A (ru) Способ лечения эндокринных нарушений голоса
IT1288918B1 (it) Apparecchiatura termoginnica per il trattamento del corpo umano
IT213162Z2 (it) Dispositivo perfezionato perl'abbronzatura artificiale integrale o parziale.